NCT02813811View on ClinicalTrials.gov

Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up.

CompletedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

May 24, 2016

Primary Completion Date

February 17, 2021

Study Completion Date

February 17, 2021

Conditions
Asthma
Trial Locations (1)

PO6 3LY

Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth

All Listed Sponsors
collaborator

Airsonett AB

INDUSTRY

lead

Portsmouth Hospitals NHS Trust

OTHER_GOV

NCT02813811 - Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up. | Biotech Hunter | Biotech Hunter